Contact Information
Company Information
Company
Engrail Therapeutics
Total Funding
231000000.0
Technologies
Outlook
Microsoft Office 365
Google Cloud Hosting
Nginx
WordPress.org
Google Tag Manager
Google Font API
Mobile Friendly
Remote
AI
Android
SharePoint
Flutter
Python
Micro
Circle
Reviews
PEO
Keywords
biotechnology
pharmaceuticals
drug development
drug discovery
life sciences
pharmaceutical manufacturing
neuroscience
pharmaceutical
clinical-stage
precision-targeted
transformational therapies
neuropsychiatric disorders
neurodevelopmental disorders
gaba a positive allosteric modulator
generalized anxiety disorder
gad treatment
dopamine d2/d3 receptor antagonist
major depressive disorder
mdd treatment
anhedonia
copper transport
menkes disease
copper ionophore
neurodegeneration
antidepressant
serotonin modulation
5-ht1a
5-ht2a receptor
posttraumatic stress disorder
ptsd
neurotransmission
mental health
clinical trials
phase 2 study
drug efficacy
treatment adherence
neuroscience pipeline
drug pharmacokinetics
biopharmaceutical
clinical operations
drug approval
neurocircuitry
clinical research
patient-centric therapies
clinical capabilities
partnerships
biochemical mechanisms
disease management
functional outcomes
chronic conditions
psychiatric diseases
evidence-based therapies
innovative treatments
medical
hospital & health care
health care
health
wellness & fitness
Get Full Contact Details
Subscribe to reveal email addresses and export contacts.
View Plans